Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,426,818
-
Share change
-
+12,281,210
-
Total reported value
-
$1,202,354,184
-
Put/Call ratio
-
145%
-
Price per share
-
$33.94
-
Number of holders
-
120
-
Value change
-
+$425,965,449
-
Number of buys
-
93
-
Number of sells
-
29
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q3 2019
As of 30 Sep 2019,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,426,818 shares.
The largest 10 holders included
Redmile Group, LLC, New Leaf Venture Partners, L.L.C., MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., JANUS HENDERSON GROUP PLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.